Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-403.21M
↓ 9804% vs avg
Percentile
P0
Near historical low
Streak
9 yr
Consecutive declineContracting
Average
$4.16M
Historical baseline
PeriodValueYoY Change
2025$-403.21M-37.9%
2024$-292.37M-55.4%
2023$-188.16M-22.5%
2022$-153.65M-28.5%
2021$-119.56M-157.1%
2020$-46.51M-293.0%
2019$-11.83M-184.2%
2018$-4.16M-100.7%
2017$585.00M-13.5%
2016$676.00M-